The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)
Open accessAbstract
Approximately 70-75% of women will have vulvovaginal candidosis (VVC) at least once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and women with acute VVC, Candida albicans is the predominant species. The diagnosis of VVC should be based on clinical symptoms and microscopic detection of pseudohyphae. Symptoms alone do not allow reliable differentiation of the causes of vaginitis. In recurrent or complicated cases, diagnostics should involve fungal culture with species identification. Serological determination of antibody titres has no role in VVC. Before the induction of therapy, VVC should always be medically confirmed. Acute VVC can be treated with local imidazoles, polyenes or ciclopirox olamine, using vaginal tablets, ovules or creams. Triazoles can also be prescribed orally, together with antifungal creams, for the treatment of the vulva. Commonly available antimycotics are generally well tolerated, and the different regimens show similarly good results. Antiseptics are potentially effective but act against the physiological vaginal flora. Neither a woman with asymptomatic colonisation nor an asymptomatic sexual partner should be treated. Women with chronic recurrent Candida albicans vulvovaginitis should undergo dose-reducing maintenance therapy with oral triazoles. Unnecessary antimycotic therapies should always be avoided, and non-albicans vaginitis should be treated with alternative antifungal agents. In the last 6 weeks of pregnancy, women should receive antifungal treatment to reduce the risk of vertical transmission, oral thrush and diaper dermatitis of the newborn. Local treatment is preferred during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This may be due to the fact that some diabetic patients are treated with SGLT2 inhibitors (e.g., dapagliflozin and canagliflozin), which are supposed to increase the number of VVC episodes [26].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
In the citing paper
“Currently available guidelines are largely consistent when it comes to the usage of azoles in the therapy of VVC in pregnant women [26,36].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
In the citing paper
“a possible teratogenic effect is possible with 400 to 800 mg of fluconazole daily [26].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
In the citing paper
“For this reason, vaginal miconazole or clotrimazole may be a safer treatment.”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
In the citing paper
“While studies have not shown an increased risk of birth defects as a result of the use of 150 mg of fluconazole during pregnancy”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
In the citing paper
“According to the latest guidelines prepared by the previously mentioned German research group, the most desirable treatment scheme is in line with the previously mentioned schemes and includes the use of clotrimazole locally.”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270
Fidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Potential Role of Phospholipases in Virulence and Fungal Pathogenesis
Ghannoum, M. A. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.122-143.2000 · Cited by 823
Romani, L. R. (2003) · Nature reviews. Immunology · doi:10.1038/nri1255 · Cited by 759
Human dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
Aagaard, K. M., Riehle, K. P., Ma, J., Segata, N., Mistretta, T., Coarfa, C., Raza, S., Rosenbaum, S., den Veyver, I. B. V., Milosavljevic, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036466 · Cited by 742
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639
Odds, F. C., & Bernaerts, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1923-1929.1994 · Cited by 631
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033114 · Cited by 487
Richter, S. S., Galask, R. P., Messer, S. A., Hollis, R. J., Diekema, D. J., & Pfaller, M. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2155-2162.2005 · Cited by 435
Candida albicans proteinases and host/pathogen interactions
Naglik, J. R., Albrecht, A., Bader, O., & Hube, B. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00439.x · Cited by 402
Rippon, J. W. (1989) · JAMA · doi:10.1001/jama.1989.03430190139055 · Cited by 398
Evaluation of Vaginal Complaints
Anderson, M. (2004) · JAMA · doi:10.1001/jama.291.11.1368 · Cited by 375
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
Willems, H. M. E., Ahmed, S. S., Liu, J., Xu, Z., & Peters, B. M. (2020) · Journal of Fungi · doi:10.3390/jof6010027 · Cited by 357
Kiss, H., Petričević, L., & Husslein, P. W. (2004) · BMJ · doi:10.1136/bmj.38169.519653.eb · Cited by 329
Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis
Hilton, E., Isenberg, H. D., Alperstein, P., France, K., & Borenstein, M. T. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-5-353 · Cited by 288
Yano, J., Sobel, J. D., Nyirjesy, P., Sobel, R., Williams, V. L., Yu, Q., Noverr, M. C., & Fidel, P. L. (2019) · BMC Women's Health · doi:10.1186/s12905-019-0748-8 · Cited by 270
Foxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261
Probiotics for prevention of recurrent vulvovaginal candidiasis: a review
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl246 · Cited by 248
Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes
de Leon, E. M., Jacober, S. J., Sobel, J. D., & Foxman, B. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-1 · Cited by 246
A comparison of secretory proteinases from different strains ofCandida albicans
Rüchel, R., Tegeler, R., & Trost, M. (1982) · Medical Mycology · doi:10.1080/00362178285380341 · Cited by 240
Candidalysin: discovery and function in Candida albicans infections
Naglik, J. R., Gaffen, S. L., & Hube, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.06.002 · Cited by 236
Schmidt, C. S., White, C. J., Ibrahim, A. S., Filler, S. G., Fu, Y., Yeaman, M. R., Edwards, J. E., & Hennessey, J. P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.038 · Cited by 233
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm
Eckert, L. O. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00264-6 · Cited by 232
Adherence of Candida albicans to Human Vaginal and Buccal Epithelial Cells
Sobel, J. D., Myers, P. G., Kaye, D., & Levison, M. E. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/143.1.76 · Cited by 231
Edwards, J. E., Schwartz, M. M., Schmidt, C. S., Sobel, J. D., Nyirjesy, P., Schodel, F., Marchus, E., Lizakowski, M., DeMontigny, E. A., Hoeg, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy185 · Cited by 213
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine
Sobel, J. D., Chaim, W., Nagappan, V., & Leaman, D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00726-9 · Cited by 206
Candida dubliniensis: phylogeny and putative virulence factors
Gilfillan, G. D., Sullivan, D. J., Parkinson, T., Coleman, D. C., & Gow, N. A. R. (1998) · Microbiology · doi:10.1099/00221287-144-4-829 · Cited by 201
Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B., Sullivan, D. J., & Coleman, D. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1819 · Cited by 197
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis
Ferris, D. G. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01759-8 · Cited by 196
Hummelen, R., Macklaim, J. M., Bisanz, J. E., Hammond, J.-A., McMillan, A., Vongsa, R., Koenig, D. W., Gloor, G. B., & Reid, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026602 · Cited by 192
An epidemiological survey of vulvovaginal candidiasis in Italy
Corsello, S., Spinillo, A., Osnengo, G., Penna, C., Guaschino, S., Beltrame, A., Blasi, N., & Festa, A. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00096-4 · Cited by 181
Evidence for a Correlation Between Proteinase Secretion and Vulvovaginal Candidosis
Cassone, A., Bernardis, F. D., Mondello, F., Ceddia, T., & Agatensi, L. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.5.777 · Cited by 171
Muzny, C. A., & Schwebke, J. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ353 · Cited by 165
The Complexity of Fungal β-Glucan in Health and Disease: Effects on the Mononuclear Phagocyte System
Camilli, G., Tabouret, G., & Quintin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00673 · Cited by 162
Treatment of Torulopsis glabrata Vaginitis: Retrospective Review of Boric Acid Therapy
Sobel, J. D., & Chaim, W. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.649 · Cited by 161
Repeated Vulvovaginal Fungal Infections Cause Persistent Pain in a Mouse Model of Vulvodynia
Farmer, M. A., Taylor, A. M. W., Bailey, A. L., Tuttle, A. H., MacIntyre, L., Milagrosa, Z. E., Crissman, H. P., Bennett, G. J., Ribeiro‐da‐Silva, A., Binik, Y. M., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002613 · Cited by 149
Chronic fungal vaginitis: The value of cultures
Nyirjesy, P., Seeney, S. M., GRODY, M. H. T., Jordan, C. A., & BUCKLEY, H. R. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90347-x · Cited by 146
Goswami, R., Dadhwal, V., Tejaswi, S., Datta, K., Paul, A., Haricharan, R. N., Banerjee, U., & Kochupillai, N. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0723 · Cited by 146
de Jong, M. A. W. P., Vriend, L. E. M., Theelen, B., Taylor, M. E., Fluitsma, D. M., Boekhout, T., & Geijtenbeek, T. B. H. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.016 · Cited by 146
Niewerth, M., Kunze, D., Seibold, M., Schaller, M., Körting, H. C., & Hube, B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1805-1817.2003 · Cited by 145
Self-citationInnate Host Defense of Human Vaginal and CervicalMucosae
Cole, A. M. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_8 · Cited by 140
Nyirjesy, P., Sobel, J. D., Fung, A., Mayer, C., Capuano, G. A., Ways, K., & Usiskin, K. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.890925 · Cited by 139
Pirotta, M. V., & Garland, S. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00218-06 · Cited by 136
Pirotta, M. V., Gunn, J. M., Chondros, P., Grover, S. R., O'Malley, P., Hurley, S., & Garland, S. M. (2004) · BMJ · doi:10.1136/bmj.38210.494977.de · Cited by 136
Vaginal Yeast Colonization in Nonpregnant Women: A Longitudinal Study
Beigi, R. H., Meyn, L. A., Moore, D. M., Krohn, M. A., & Hillier, S. L. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000140687.51048.73 · Cited by 134
The epidemiology of vulvovaginal candidiasis: risk factors.
Foxman, B. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.3.329 · Cited by 133
Aballéa, S., Guelfucci, F., Wagner, J., Khemiri, A., Dietz, J.-P., Sobel, J. D., & Toumi, M. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-169 · Cited by 131
Babula, O., Lazdane, G., Kroica, J., Linhares, I. M., Ledger, W. J., & Witkin, S. S. (2005) · Clinical Infectious Diseases · doi:10.1086/429246 · Cited by 130
Probiotics for vulvovaginal candidiasis in non-pregnant women
Xie, H. Y., Feng, D., Wei, D. M., Mei, L., Chen, H., Wang, X., & Fang, F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010496.pub2 · Cited by 129
Molecular aspects of fluconazole resistance development in Candida albicans
Franz, R., Ruhnke, M., & Morschhäuser, J. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00498.x · Cited by 129
Self-citationHormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis
van de Wijgert, J. H. H. M., Verwijs, M. C., Turner, A. N., & MORRISON, C. S. (2013) · AIDS · doi:10.1097/qad.0b013e32836290b6 · Cited by 128
Donders, G., Bellen, G., Byttebier, G., Verguts, L., Hinoul, P., Walckiers, R., Stalpaert, M., Vereecken, A., & Van Eldere, J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.029 · Cited by 127
Chew, S. Y., Cheah, Y. K., Seow, H. F., Sandai, D. A., & Than, L. T. L. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12772 · Cited by 126
Bernardis, F. D., Agatensi, L., Ross, I. K., Emerson, G. W., Lorenzini, R., Sullivan, P. A., & Cassone, A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.6.1276 · Cited by 126
Vermitsky, J., Self, M. J., Chadwick, S. G., Trama, J. P., Adelson, M. E., Mordechai, E., & Gygax, S. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02485-07 · Cited by 123
Sobel, J. D., Zervos, M., Reed, B. D., Hooton, T. M., Soper, D. E., Nyirjesy, P., Heine, M. W., Willems, J., & Panzer, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.34-38.2003 · Cited by 122
Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects
Mølgaard‐Nielsen, D., Pasternak, B., & Hviid, A. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301066 · Cited by 120
Candida dubliniensis: Ten years on
Sullivan, D. J., Moran, G. P., & Coleman, D. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.015 · Cited by 117
Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy
Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.93 · Cited by 117
Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)
Mendling, W. (2015) · Mycoses · doi:10.1111/myc.12292 · Cited by 117
Self-citationInfection through structured polymicrobial Gardnerella biofilms (StPM-GB).
Swidsinski, A. V., Loening-Baucke, V. A., Mendling, W., Dörffel, Y., Schilling, J., Halwani, Z., Jiang, X., Verstraelen, H., & Swidsinski, S. (2014) · PubMed · doi:10.14670/hh-29.10.567 · Cited by 113
Self-citationOrofacial pain and temporomandibular disorders: the impact on oral health and quality of life
Conti, P. C. R., Fiamengui, L. M. S. P., Cunha, C. O., & Conti, A. C. D. C. F. (2012) · Brazilian Oral Research · doi:10.1590/s1806-83242012000700018 · Cited by 112
Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole
Mastroiacovo, P., Mazzone, T., Botto, L. D., Serafini, M. A., Finardi, A., Caramelli, L., & Fusco, D. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70119-9 · Cited by 111
Mendling, W., & Brasch, J. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02185.x · Cited by 110
Self-citationReproductive health in young women with cystic fibrosis: Knowledge, behavior and attitudes
Sawyer, S. M., Phelan, P. D., & Bowes, G. (1995) · Journal of Adolescent Health · doi:10.1016/1054-139x(94)00096-w · Cited by 110
Pathogenicity determinants of Candida
Ghannoum, M. A., & Abu‐Elteen, K. H. (1990) · Mycoses · doi:10.1111/myc.1990.33.6.265 · Cited by 109
Mølgaard‐Nielsen, D., Svanström, H., Melbye, M., Hviid, A. P., & Pasternak, B. (2016) · JAMA · doi:10.1001/jama.2015.17844 · Cited by 107
Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: “Neutrophil Anergy”
Yano, J., Peters, B. M., Noverr, M. C., & Fidel, P. L. (2017) · Infection and Immunity · doi:10.1128/iai.00684-17 · Cited by 107
Ray, D., Goswami, R., Banerjee, U., Dadhwal, V., Goswami, D., Mandal, P., Sreenivas, V., & Kochupillai, N. (2007) · Diabetes Care · doi:10.2337/dc06-1469 · Cited by 105
Goswami, D., Goswami, R., Banerjee, U., Dadhwal, V., Miglani, S., Lattif, A. A., & Kochupillai, N. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.03.005 · Cited by 104
Paulitsch‐Fuchs, A. H., Weger, W., Ginter‐Hanselmayer, G., Marth, E., & Buzina, W. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01284.x · Cited by 102
The impact of oral contraception on vulvovaginal candidiasis
Spinillo, A., Capuzzo, E., Nicola, S., et al. (1995) · Contraception · doi:10.1016/0010-7824(95)00079-p · Cited by 101
Vaginitis Due to Candida krusei: Epidemiology, Clinical Aspects, and Therapy
Singh, S., Sobel, J. D., Bhargava, P., Boikov, D. A., & Vazquez, J. A. (2002) · Clinical Infectious Diseases · doi:10.1086/343826 · Cited by 100
Roberts, C. L., Rickard, K., Kotsiou, G., & Morris, J. M. (2011) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-11-18 · Cited by 100
Effect of Antibiotics on Vulvovaginal Candidiasis: A MetroNet Study
Xu, J., Schwartz, K., Bartoces, M. G., Monsur, J. C., Severson, R. K., & Sobel, J. D. (2008) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2008.04.070169 · Cited by 100
Unnikrishnan, A., Kalra, S., Purandare, V. B., & Vasnawala, H. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_159_17 · Cited by 100
Pendharkar, S., Brandsborg, E., Hammarström, L. L. G., Marcotte, H., & Larsson, P. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0971-3 · Cited by 99
Seta, F. D., Parazzini, F., Leo, R. D., Banco, R., Maso, G., Santo, D. D., Sartore, A., Stabile, G., Inglese, S., Tonon, M., et al. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.018 · Cited by 97
Odds, F. C., Arai, T., DiSalvo, A. F., Evans, E. G. V., Hay, R. J., Randhawa, H. S., Rinaldi, M. G., & Walsh, T. J. (1992) · Medical Mycology · doi:10.1080/02681219280000021 · Cited by 96
Probiotics for Treatment and Prevention of Urogenital Infections in Women: A Systematic Review
Hanson, L., VandeVusse, L., Jermé, M., Abad, C. L. R., & Safdar, N. (2016) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12472 · Cited by 96
Accuracy of the Clinical Diagnosis of Vaginitis Compared With a DNA Probe Laboratory Standard
Lowe, N. K., Neal, J. L., & Ryan‐Wenger, N. A. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181909f63 · Cited by 95
Oestrogen, glycogen and vaginal candidiasis
Dennerstein, G., & Ellis, D. H. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01238.x · Cited by 95
Topical treatment for vaginal candidiasis (thrush) in pregnancy
Young, G., & Jewell, D. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000225 · Cited by 94
Russo, R., Superti, F., Karadja, E., & De Seta, F. (2019) · Mycoses · doi:10.1111/myc.12883 · Cited by 94
Ip, W., & Lau, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/422397 · Cited by 92
Recent progress in vaccines against fungal diseases
Cassone, A., & Casadevall, A. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.004 · Cited by 91
Use of Locally Delivered Dequalinium Chloride in the Treatment of Vaginal Infections: A Review
Mendling, W., Weissenbacher, E. R., Gerber, S., Prasauskas, V., & Grob, P. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3914-8 · Cited by 91
Selection of Lactobacillus strains as potential probiotics for vaginitis treatment
Santos, C. M. A., Pires, M. C. V., Leão, T. L., Hernández, Z. P., Rodriguez, M. L., Martins, A. K. S., Miranda, L. S., Martins, F. S., & Nicoli, J. R. (2016) · Microbiology · doi:10.1099/mic.0.000302 · Cited by 91
Immunity in vaginal candidiasis
Fidel, P. L. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000160897.74492.a3 · Cited by 89
Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis
Auler, M. E., Morreira, D., Rodrigues, F. F. O., Ão, M. S. A., Margarido, P. F. R., Matsumoto, F. E., Silva, E. G., da Silva, B. C. M., Schneider, R. P., & Paula, C. R. (2010) · Medical Mycology · doi:10.3109/13693780902856626 · Cited by 89
Donders, G. G. G., Babula, O., Bellen, G., Linhares, I. M., & Witkin, S. S. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01830.x · Cited by 88
Watson, M. C., Grimshaw, J., Bond, C. M., Mollison, J., & Ludbrook, A. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01142.x · Cited by 87
Rylander, E. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.004192 · Cited by 87
Martinez, R. C. R., Seney, S. L., Summers, K. L., Nomizo, A., Martinis, E. C. P. D., & Reid, G. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2009.00154.x · Cited by 86
Roberts, C. L., Algert, C. S., Rickard, K., & Morris, J. M. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0018-2 · Cited by 84
Management of Recurrent Vulvo-Vaginal Candidosis as a Chronic Illness
Donders, G. G. G., Bellen, G., & Mendling, W. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000314022 · Cited by 83
Self-citationNLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans
Roselletti, E., Perito, S., Gabrielli, E., Mencacci, A., Pericolini, E., Sabbatini, S., Cassone, A., & Vecchiarelli, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17649-8 · Cited by 83
Can intrauterine contraceptive devices be a Candida albicans reservoir?
Chassot, F., Negri, M., Svidzinski, A. E., Donatti, L., Peralta, R. M., Svidzinski, T. I. E., & Consolaro, M. E. L. (2008) · Contraception · doi:10.1016/j.contraception.2008.01.007 · Cited by 81
Candida africana and its closest relatives
Romeo, O., & Criseo, G. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01939.x · Cited by 79
Propolis Is an Efficient Fungicide and Inhibitor of Biofilm Production by VaginalCandida albicans
Capoci, I. R. G., Mendonca, P., Arita, G. S., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/287693 · Cited by 79
Brand, S. R., Degenhardt, T. P., Person, K., Sobel, J. D., Nyirjesy, P., Schotzinger, R. J., & Tavakkol, A. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.03.001 · Cited by 78
Vulvovaginal Candidiasis in Postmenopausal Women
Fischer, G. O., & Bradford, J. A. (2011) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3182241f1a · Cited by 76
Zhang, X., Liao, Q., Wang, F., & Li, D. (2018) · Medicine · doi:10.1097/md.0000000000011891 · Cited by 76
Recurrent allergic vulvovaginitis: Treatment with Candida albicans allergen immunotherapy
Rigg, D., Miller, M. M., & Metzger, W. J. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90380-p · Cited by 75
Key Note Lecture Review article Vulvovaginitis due to Candida glabrata. An emerging problem
Sobel, J. D. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00594.x · Cited by 74
Spinillo, A., Capuzzo, E., Egbe, T. O., Baltaro, F., Nicola, S., & Piazzi, G. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00047-u · Cited by 72
Gaspard, U., Scheen, A., Endrikat, J., Buicu, C., Lefebvre, P., Gerlinger, C., & Heithecker, R. (2003) · Contraception · doi:10.1016/s0010-7824(02)00537-1 · Cited by 72
Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome
Farr, A., Kiss, H., Holzer, I., Husslein, P. W., Hagmann, M., & Petričević, L. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12697 · Cited by 70
Self-citationLocal Treatment of Vulvovaginal Candidosis
das Neves, J., Pinto, E., Teixeira, B., Dias, G., Rocha, P., Cunha, T., Santos, B., Amaral, M. H., & Bahia, M. F. (2008) · Drugs · doi:10.2165/00003495-200868130-00002 · Cited by 69
Identification of novel mechanisms involved in generating localized vulvodynia pain
Falsetta, M. L., Foster, D. C., Woeller, C. F., Pollock, S. J., Bonham, A. D., Haidaris, C. G., Stodgell, C. J., & Phipps, R. P. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.002 · Cited by 69
Candida albicans: Cellular immune system interactions during different stages of the menstrual cycle
Kalo-Klein, A., & Witkin, S. S. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90649-2 · Cited by 69
DAMP signaling in fungal infections and diseases
Cunha, C., Carvalho, A., Esposito, A., Bistoni, F., & Romani, L. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00286 · Cited by 69
Candida Transmission and Sexual Behaviors as Risks for a Repeat Episode of Candida Vulvovaginitis
Reed, B. D., Zazove, P., Pierson, C. L., Gorenflo, D. W., & Horrocks, J. (2003) · Journal of Women s Health · doi:10.1089/154099903322643901 · Cited by 68
Association of Recurrent Vaginal Candidiasis and Secretory ABO and Lewis Phenotype
Chaim, W., Foxman, B., & Sobel, J. D. (1997) · The Journal of Infectious Diseases · doi:10.1086/517314 · Cited by 68
“Not thrush again!” Women's experience of post‐antibiotic vulvovaginitis
Pirotta, M. V., Gunn, J. M., & Chondros, P. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05418.x · Cited by 66
Treatment of Vulvovaginal Candidiasis in Patients With Diabetes
Bohannon, N. J. V. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.451 · Cited by 66
Treatment of Non-Albicans Candida Vaginitis with Amphotericin B Vaginal Suppositories
Phillips, A. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.034 · Cited by 66
Mathema, B., Cross, E., Dun, E., Park, S., Bedell, J., Slade, B., Williams, M., Riley, L., Chaturvedi, V., & Perlin, D. S. (2001) · Clinical Infectious Diseases · doi:10.1086/322600 · Cited by 65
Impaired tolerance for glucose in women with recurrent vaginal candidiasis
Donders, G. G. G., Prenen, H., Verbeke, G. N., & Reybrouck, R. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126285 · Cited by 63
Beghini, J., Linhares, I. M., Giraldo, P. C., Ledger, W., & Witkin, S. S. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13072 · Cited by 63
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
Sobel, J. D. (1985) · PubMed · Cited by 62
Olsen, J., & Andersen, P. K. (1999) · Epidemiology · doi:10.1097/00001648-199907000-00013 · Cited by 61
Asymptomatic trichomonas and candida colonization and pregnancy outcome
Hay, P., & Czeizel, A. E. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.02.002 · Cited by 61
Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair
Crompton, R. A., Williams, H., Ansell, D. M., Campbell, L., Holden, K. A., Cruickshank, S. M., & Hardman, M. J. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.160 · Cited by 61
Microbial flora associated with Candida albicans vulvovaginitis
Auger, P., & Joly, J. (1980) · Obstetrics and Gynecology · doi:10.1097/00006250-198003000-00029 · Cited by 59
Association between atopy and recurrent vaginal candidiasis
Neves, N. A., Carvalho, L. P., de Oliveira, M. A. M., Giraldo, P. C., Bacellar, O., Cruz, Ã. A., & Carvalho, E. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02891.x · Cited by 58
Co‐treatment of the male partner in vaginal candidosis: a double‐blind randomized control study
Bisschop, M. P. J. M., Merkus, J. M. W. M., Scheygrond, H., & Cutsem, J. V. (1986) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07818.x · Cited by 58
Preterm birth reduction after clotrimazole treatment during pregnancy
Czeizel, A. E., Fladung, B., & Vargha, P. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.02.011 · Cited by 58
Diagnosis of Vaginal Discharge by Wet Mount Microscopy: A Simple and Underrated Method
Mylonas, I. G., & Bergauer, F. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31822bdf31 · Cited by 58
Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure
Shukla, A., & Sobel, J. D. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0700-y · Cited by 57
Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells
Ho, J., Wickramasinghe, D. N., Nikou, S.-A., Hube, B., Richardson, J. P., & Naglik, J. R. (2020) · Cells · doi:10.3390/cells9030699 · Cited by 57
Weissenbacher, T., Witkin, S. S., Ledger, W. J., Tolbert, V., Gingelmaier, A., Scholz, C., Weissenbacher, E. R., Friese, K., & Mylonas, I. G. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0681-9 · Cited by 56
Contact allergy to beeswax and propolis among patients with cheilitis or facial dermatitis
Nyman, G. S. A., Tang, M., Inerot, A., et al. (2019) · Contact Dermatitis · doi:10.1111/cod.13306 · Cited by 56
Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment
Davidson, F., & Mould, R. F. (1978) · Sexually Transmitted Infections · doi:10.1136/sti.54.3.176 · Cited by 55
Fluconazole use and birth defects in the National Birth Defects Prevention Study
Howley, M. M., Carter, T. C., Browne, M. L., Romitti, P. A., Cunniff, C. M., & Druschel, C. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.022 · Cited by 54
Nurbhai, M., Grimshaw, J., Watson, M. C., Bond, C. M., Mollison, J., & Ludbrook, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002845.pub2 · Cited by 54
Houston, D. K., Neiberg, R. H., Miller, M. E., Hill, J. O., Jakicic, J. M., Johnson, K. C., Gregg, E. W., Hubbard, V. S., Pi-Sunyer, X., Rejeski, W. J., et al. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx204 · Cited by 52
Prevention and Treatment of Vulvovaginal Candidiasis Using Exogenous Lactobacillus
Jeavons, H. S. (2003) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1177/0884217503253439 · Cited by 51
Signs of chronic stress in women with recurrent candida vulvovaginitis
Ehrström, S., Kornfeld, D., Thuresson, J., & Rylander, E. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.068 · Cited by 50
Prevalence and management of non-albicans vaginal candidiasis
Hetticarachchi, N., Ashbee, H. R., & Wilson, J. D. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2009.040386 · Cited by 50
Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candiosis
Mårdh, P., Novikova, N., & Stukalova, E. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2003.01445.x · Cited by 49
The colonization with Candida species is more harmful in the second trimester of pregnancy
Holzer, I., Farr, A., Kiss, H., Hagmann, M., & Petričević, L. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4331-y · Cited by 48
Self-citationFarrell, S. M., Hawkins, D. F., & Ryder, T. A. (1983) · Medical Mycology · doi:10.1080/00362178385380391 · Cited by 47
No Teratogenic Effect after Clotrimazole Therapy during Pregnancy
Czeizel, A. E., Tóth, M., & Rockenbauer, M. (1999) · Epidemiology · doi:10.1097/00001648-199907000-00016 · Cited by 47
The pill does not cause ‘thrush’
Davidson, F., & Oates, J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb04873.x · Cited by 46
New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges
Vecchiarelli, A., Pericolini, E., Gabrielli, E., & Pietrella, D. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00294 · Cited by 45
Cassone, A., Bernardis, F. D., & Torososantucci, A. (2005) · Current Molecular Medicine · doi:10.2174/1566524054022549 · Cited by 45
Thoden, J., Potthoff, A. V., Bogner, J. R., Brockmeyer, N. H., Esser, S., Grabmeier‐Pfistershammer, K., Haas, B. J., Hahn, K., Härter, G., Hartmann, M., et al. (2013) · Infection · doi:10.1007/s15010-013-0504-1 · Cited by 43
Self-citationHyposensitisation in the management of recurring vaginal candidiasis.
Rosedale, N., & Browne, K. (1979) · PubMed · Cited by 42
Meyer, H., Goettlicher, S., & Mendling, W. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01235.x · Cited by 42
Self-citationRelationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid
Weissenbacher, T. M., Witkin, S. S., Gingelmaier, A., Scholz, C., Friese, K., & Mylonas, I. G. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.01.010 · Cited by 42
Epidemiologische Untersuchungen zum Vorkommen von Hefepilzen bei Kindern und deren Müttern*
Blaschke-Hellmessen, R. (1968) · Mycoses · doi:10.1111/j.1439-0507.1968.tb03398.x · Cited by 42
Huang, Y., Merkatz, R. B., Hillier, S. L., Roberts, K. D., Blithe, D., Sitruk-Ware, R. L., & Creinin, M. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134460 · Cited by 41
Antimicrobial Activity of Dequalinium Chloride against Leading Germs of Vaginal Infections
Casa, V. D., Noll, H., Gonser, S., Grob, P., Graf, F., & Pohlig, G. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1299954 · Cited by 40
Pericolini, E., Perito, S., Castagnoli, A., Gabrielli, E., Mencacci, A., Blasi, E., Vecchiarelli, A., & Wheeler, R. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201436 · Cited by 40
Mendling, W., & Koldovsky, U. (1996) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744996000439 · Cited by 40
Self-citationIdentification of CARE ‐2‐negative Candida albicans isolates as Candida dubliniensis
Morschhäuser, J., Ruhnke, M., Michel, S., & Hacker, J. H. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00259.x · Cited by 39
Self-citationLi, J., Fan, S., Liu, X., Li, D. M., Nie, Z., Li, F., Lin, H., Huang, W., Zong, L., Jin, J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592249 · Cited by 39
Vaginal Candida parapsilosis: pathogen or bystander?
Nyirjesy, P., Alexander, A. B., & Weitz, M. V. (2005) · PubMed · doi:10.1080/10647440400025603 · Cited by 38
Pitsouni, E. I., Iavazzo, C. R., & Falagas, M. E. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.786 · Cited by 37
Vulvovaginal candidiasis in young women with cystic fibrosis
Sawyer, S. M., Bowes, G., & Phelan, P. D. (1994) · BMJ · doi:10.1136/bmj.308.6944.1609 · Cited by 37
Witt, A., Kaufmann, U., Bitschnau, M., Tempfer, C. M., Özbal, A., Haytouglu, E., Gregor, H., & Kiss, H. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02262.x · Cited by 37
Zhou, X., Li, T., Fan, S., Zhu, Y., Liu, X., Guo, X., & Liang, Y. (2016) · Mycoses · doi:10.1111/myc.12485 · Cited by 37
Donders, G. G. G., Bellen, G., Ruban, K., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000657 · Cited by 37
Vaginal Candida parapsilosis: Pathogen or Bystander?
Nyirjesy, P., Alexander, A. B., & Weitz, M. V. (2005) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2005/401530 · Cited by 37
Mendling, W., Krauss, C., & Fladung, B. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00970.x · Cited by 36
Self-citationProbiotics as antifungal agents: Experimental confirmation and future prospects
Kosgey, J. C., Jia, L., Fang, Y., Yang, J., Gao, L., Wang, J., Nyamao, R. M., Cheteu, M., Tong, D., Wekesa, V. W., et al. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.05.001 · Cited by 36
Roselletti, E., Monari, C., Sabbatini, S., Perito, S., Vecchiarelli, A., Sobel, J. D., & Cassone, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02669 · Cited by 36
Yeast Infections — Human Genetics on the Rise
Holland, S. M., & Vinh, D. C. (2009) · New England Journal of Medicine · doi:10.1056/nejme0907186 · Cited by 35
Raška, M., Běláková, J., Raška, M., Běláková, J., Horynová, M., Křupka, M., Novotný, J., Šebestová, M., & Weigl, E. (2008) · Medical Mycology · doi:10.1080/13693780701883508 · Cited by 34
Treatment of Vaginal Candidosis with Natamycin and Effect of Treating the partner at the same time
Buch, A., & Christensen, E. S. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209156578 · Cited by 32
Zhao, X., Malloy, P. J., Ardies, C. M., et al. (1995) · Microbiology · doi:10.1099/13500872-141-10-2685 · Cited by 32
Špaček, J., Jílek, P., Buchta, V., Förstl, M., Hronek, M., & Holečková, M. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01164.x · Cited by 32
Fan, S., Liu, X., & Liang, Y. (2015) · Gynecologic and Obstetric Investigation · doi:10.1159/000371759 · Cited by 31
Giraldo, P. C., Neuer, A., Korneeva, I., Ribeiro-Filho, A., Simões, J. A., & Witkin, S. S. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70248-6 · Cited by 30
Healey, K. R., Katiyar, S. K., Castanheira, M., Pfaller, M. A., & Edlind, T. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00044-11 · Cited by 30
Ahangari, F., Farshbaf‐Khalili, A., Javadzadeh, Y., Adibpour, M., & Oskouei, B. S. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13918 · Cited by 30
Penicillin Therapy in Acute Bacterial Endocarditis
DOLPHIN, A. C., & Cruickshank, R. (1945) · BMJ · doi:10.1136/bmj.1.4408.897 · Cited by 29
Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis
Friese, K., Neumann, G., & Siebert, J. (2003) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-002-0368-6 · Cited by 29
Vaginal yeasts in the era of "over the counter" antifungals
Walker, P. P. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.6.437 · Cited by 29
Roth, A. C., Milsom, I., Forssman, L., & Wåhlén, P. (1990) · Sexually Transmitted Infections · doi:10.1136/sti.66.5.357 · Cited by 28
Mendling, W., & Koldovsky, U. (1996) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1002/(sici)1098-0997(1996)4:4 · Cited by 28
Self-citationPotential role of probiotic bacteria in the treatment and prevention of localised candidosis
Mailänder‐Sánchez, D., Wagener, J., & Schaller, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01967.x · Cited by 27
Self-citationCandida vulvovaginitis: A store with a buttery and a show window
Donders, G. G. G., & Sobel, J. D. (2016) · Mycoses · doi:10.1111/myc.12572 · Cited by 27
Sharma, C., Muralidhar, S., Xu, J., Meis, J. F. G. M., & Chowdhary, A. (2014) · Mycoses · doi:10.1111/myc.12193 · Cited by 26
Candida albicans allergen immunotherapy in recurrent vaginal candidiasis.
Moraes, P., Goiaba, S. D. L., & Taketomi, E. A. (2001) · PubMed · Cited by 25
Trumbore, D. J., & Sobel, J. D. (1986) · PubMed · Cited by 23
Antimicrobial Topical Agents Used in the Vagina
Tirri, B. F. (2011) · Current problems in dermatology · doi:10.1159/000321047 · Cited by 23
Marschalek, J., Farr, A., Kiss, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155182 · Cited by 23
Self-citationSavini, V., Catavitello, C., Manna, A., Talia, M., Febbo, F., Balbinot, A., D’Antonio, F., Bonaventura, G. D., Celentano, C., Liberati, M., et al. (2008) · Mycopathologia · doi:10.1007/s11046-008-9119-y · Cited by 22
Subpartale Übertragung von Candida und ihre Konsequenzen
Blaschke‐Hellmessen, R. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00598.x · Cited by 22
Hoffstetter, S., Barr, S. P., LeFevre, C., Leong, F. C., & Leet, T. L. (2008) · PubMed · Cited by 21
Immunotherapeutic approaches to enhance protective immunity againstCandidavaginitis
Wozniak, K. L., Palmer, G. E., Kutner, R. H., & Fidel, P. L. (2005) · Medical Mycology · doi:10.1080/13693780500096898 · Cited by 21
[Pharmacokinetics of imidazole-antimycotics (author's transl)].
Plempel, M. (1980) · PubMed · Cited by 21
Donders, G. G. G., Grincevičienė, Š., Bellen, G., Jaeger, M., ten Oever, J., & Netea, M. G. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12811 · Cited by 21
Die Salzsaure‐Toleranz von Candida albicans
Meinhof, W. (1974) · Mycoses · doi:10.1111/j.1439-0507.1974.tb04509.x · Cited by 20
Vaginal Candida spp. genomes from women with vulvovaginal candidiasis
Bradford, L. L., Chibucos, M. C., Ma, B., Bruno, V. M., & Ravel, J. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx061 · Cited by 19
Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies.
Wilson, C. (2005) · PubMed · Cited by 18
Research works printed but not linked: 13
- 2019, Thais Chimati Felix DvDdBR, Reginaldo dos Santos Pedroso. Alternative and complementary therapies for vulvovaginal candidiasis, Folia Microbiol, 2018, 133
- 10.1128/CMR.13.1.122 · DOI
- Dennerstein GJ, 2001, Oestrogen, glcogen and vaginal candidiasis, Obstet Gynecol, 41, 326
- Witkin S, 2000, New insights into the immune pathogenesis of recurrent vulvovaginal candidiasis, Italian J Gynaecol Obstet, 12, 114
- 10.1001/jama.291.11.1368 · DOI
- 10.1086/343826 · DOI
- 10.1155/2005/401530 · DOI
- Müller J, Monographie
- Workowski KA, 2015, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 64, 1
- Mendling W, 2008, Antimykotische Therapie der vaginalen Hefepilz‐Kolonisation von Schwangeren zur Verhütung von Kandidamykosen beim Neugeborenen, AMWF, Guideline, 15, S1
- Koldowsky H, 1999, Herstellung eines autologen membrangebundenen Candida‐Antigens und in‐vitro‐Untersuchungen zu seinen immunologischen Reaktionen, Candida‐Infektionen des weiblichen Genitaltraktes, 25
- 10.1086/429246 · DOI · Paper page
- 10.1002/(SICI)1098-0997(1996)4:4<225::AID-IDOG5>3.0.CO;2-Y · DOI
Cited by
Sorted by citations
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Satora, M., Grunwald, A., Zaremba, B., Frankowska, K., Żak, K., Tarkowski, R., & Kułak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165376 · Cited by 84
Donders, G., Sziller, I. O., Paavonen, J., Hay, P., de Seta, F., Bohbot, J. M., Kotarski, J., Vives, J. A., Szabo, B., Cepuliené, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934353 · Cited by 82
Self-citationMeng, Q., Wang, H., Xiao, W., Mai, W., Liu, Y., Xiao, Y., Wang, P., Sui, J., He, X., Yin, F., et al. (2025) · Mycology · doi:10.1080/21501203.2025.2461725 · Cited by 8
Metadata
- Authors
- Farr, A., Effendy, I., Frey Tirri, B., Hof, H., Mayser, P., Petricevic, L., Ruhnke, M., Schaller, M., Schaefer, A. P. A., Sustr, V., Willinger, B., & Mendling, W.
- Affiliations
- Medical University of Vienna (AT)
- Klinikum Bielefeld (DE)
- Frauenklinik Kantonspital Baselland Liestal Switzerland
- Labor Dr. Limbach und Kollegen Heidelberg Germany
- Facharzt für Dermatologie und Allergologie Biebertal Germany
- Division of Obstetrics and Feto‐Maternal Medicine Department of Obstetrics and Gynecology Medical University of Vienna Vienna Austria
- Helios Klinikum Aue (DE)
- Universitätsklinikum Tübingen (DE)
- Facharzt für Frauenheilkunde und Geburtshilfe Berlin Germany
- Deutsches Zentrum fuer Infektionen in Gynaekologie und Geburtshilfe Wuppertal Germany
- Corresponding author
- Farr, Alex
- ORCID
- Venue
- Mycoses
- Publisher
- Wiley
- Published
- 2021-02-27
- Volume
- 64
- Issue
- 6
- Pages
- 583-602
- ISSN
- 0027-5557 (ISSN-L)
- 0933-7407
- 1439-0507
- PMC
- PMC8248160
- OpenAlex
- W3129088316
- Cited by
- 184
- References
- 234
- Citations by year
- 2026: 31 · 2025: 52 · 2024: 38 · 2023: 32 · 2022: 25 · 2021: 6
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Mycoses (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
- Keywords
- Candida albicans, vaginal infection, antifungal therapy, imidazole, triazoles, ciclopirox olamine, polyenes, maintenance therapy, pregnancy, vertical transmission, non-albicans Candida, vaginal microbiota
- MeSH terms
- Ciclopirox, Anti-Bacterial Agents, Antifungal Agents, Candida albicans, Candidiasis, Vulvovaginal, Contraceptive Agents, Diabetes Mellitus, Female, Hormones, Humans, Imidazoles, Infant, Newborn, Polyenes, Pregnancy, Vaginitis, Causality, Hyphae, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
